Hoth Therapeutics Announces Closing of $2.0 Million Registered Direct Offering

B NEW YORK, April 2, 2026 /PRNewswire/ — Hoth Therapeutics, Inc. (Nasdaq: HOTH), a clinical-stage biopharmaceutical company focused on developing innovative therapies for unmet medical…
posteditor
posteditor
Articles: 16137

Other News